A Study On Clinical Response And Toxicity In Locally Advanced Head And Neck Cancers
DOI:
https://doi.org/10.37506/47j42r56Keywords:
Toxicities, Head & Neck cancer, Radiotherapy.Abstract
Background: Treatment of locally advanced head and neck cancer is a clinical challenge and requires aggressive and concerted measures. Radiotherapy with concurrent chemotherapy is the standard curative treatment strategy for the locally advanced head and neck cancer. The ultimate aim of radiation therapy is the maximum local control of the tumour with minimal toxicity. Objectives: To assess the clinical response of treatment using Response Evaluation Criteria In Solid Tumors (RECIST) (version1.1) criteria. To assess the toxicities among the study population during chemo-radiation. Methodology: Hospital based observational prospective study was conducted at Department of Radiation oncology, in a Tertiary cancer care centre among Head and neck Cancer patients. Results: Most common site of head and neck cancer in the study was oral cavity followed by oropharynx and hypo pharynx. At the end of 4th week 58.33% had grade1 and 33.33% grade 2 mucositis. Response to treatment was found to be statistically significant. Conclusion: Mucositis was significant toxicities during treatment followed by dysphagia and radiation dermatitis. Complete response is seen in 50% of the patients clinically and radiologically. No patient died during treatment or at follow up.
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin 2018;68:394-424
Prabhash K,et al.Indian clinical practice consensus guidelines for the management of squamous cell carcinoma of head and neck.Indian J Cancer 2020;57:SupplS1:1-5
Van der Veen J, Nuyts S. Can intensity-modulated-radiotherapy reduce toxicity in head and neck squamous cell carcinoma? Cancers (Basel) 2017; 9:135.
Tubiana M, Eschwege F. Conformal radiotherapy and intensity-modulated radiotherapy: clinical data. Acta Oncol 2000; 39:555-67.
Saptarshi Ghosh et al. Concurrent Chemo radiation with Weekly Cisplatin for the Treatment of Head and Neck Cancers: an Institutional Study on Acute Toxicity and Response to Treatment.Apjcp. December 2015;Volume 16: 7331-7335
Singh NP, Khurana R, Sapru S, Rastogi M, Gandhi AK, Rath S, et al. Long term outcome and late toxicity of SIB-IMRT in definitive management of head and neck cancers in patients not suitable for chemo-Radiotherapy. J Can Res Ther 2022; 18:1461-8.
Muhammad Shahid Iqbal et al. Primary Concurrent Chemo radiation in Head and Neck Cancers with Weekly Cisplatin Chemotherapy: Analysis of Compliance, Toxicity and Survival. Int Arch Otorhinolaryngol. 2017 Apr; 21(2):171-177
Daniel J. Givens, BS et al. Adverse Events Associated with Concurrent Chemo radiation Therapy in Patients with Head and Neck Cancer. Arch Otolaryngol Head Neck Surg.2009;135(12):1209-1217
Mauro palazzo et al. effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating ctcae, version 3.0, scoring system.IJRBP.2008;70(2):330-337
Andy Trotti et al.Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol. 2003 Mar; 66(3):253-62.
Bhide SA et al.Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers. Br J Radiol. 2012 May; 85(1013):487–494
Tejpal gupta et al. Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: A randomized controlled trial.Radiotherapy and oncology.2012; 104:343-348.
Nguyen NP et al. Dysphagia following chemoradiation for locally advanced head and neck cancer. Original articles head and neck cancer.2004;15(3):P383-388
N. Kucha et al. A prospective, comparative analysis of acute toxicity profile between three-dimensional conformal radiotherapy (3DCRT) and intensity-modulated radiotherapy (IMRT) in locally advanced head and neck cancer patients. Cancer Treatment and Research Communications 25 (2020) 10022
Pirus Ghadjar et al. Impact of weight loss on survival after chemo radiation for locally advanced head and neck Cancer: secondary results of a randomized phase III trial (SAKK 10/94). Radiat Oncol. 2015; 10:21.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
https://creativecommons.org/licenses/by-nc/2.0/deed.en